|
|
||||||||||
|
J Am Coll Cardiol, 1999; 34:1854-1856 © 1999 by the American College of Cardiology Foundation |
a Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
Reprint requests and correspondence: Dr. Valentin Fuster, Dir., Cardiovascular Institute, Mount Sinai Medical Center, One Gustav Levy Pl., Box 1030, New York, New York 10029-6574
| Angiographic morphology and the pathogenesis of unstable angina pectoris |
|---|
|
|
|---|
| Review |
|---|
|
|
|---|
Does the morphology of the coronary lesion help determine the clinical status or risk of subsequent occlusion? The historical article highlighted in this issue of the Journal was published by Ambrose et al. (3) in 1985, and it suggested that morphology does assist the cardiologist in detecting high-risk lesions. The study was undertaken in order to assess the qualitative appearance of coronary lesions in patients with either stable or unstable angina. One hundred and ten patients with either stable or unstable angina underwent cardiac catheterization. Significant lesions were categorized into four groups: a) concentric; b) type I eccentric (asymmetric narrowing with smooth borders and a broad neck); c) type II eccentric (asymmetric with a narrow neck or irregular borders, or both); and d) multiple irregular coronary narrowing in series. In all patients an attempt was made to localize the culprit artery that produced the chest pain syndrome. This artery was identified in 60% of the study patients. The artery was designated the "angina-producing" artery if it was found in patients with one-vessel disease, if it was localizable by reversible thallium perfusion defects upon exercise testing, or if reversible ST-T changes were detected on an electrocardiogram during an anginal episode. The result of this study was that the type II eccentric lesions were significantly more frequent in the patients with unstable angina than in those with stable angina. This finding was demonstrated in the entire group as well as in the sub-group of patients in which the angina-producing artery could be identified. The result of this study was important because it suggested that the trigger of acute coronary syndromes might be rupture of an atherosclerotic plaque with subsequent thrombus formation, thus forming the irregular borders seen on the angiogram.
A recent study by Tousoulis et al. (4) returned to the issue of identifying the lesion most likely to progress to complete occlusion. In their study, they analyzed both the severity of stenosis and the morphology of coronary artery lesions in patients with stable angina who later progressed to AMI. They found by analyzing serial angiograms that the lesions that subsequently completely occluded and caused clinical events were less than 50% stenosed in 58% of patients, thus confirming again that the degree of stenosis is not a good predictor of subsequent occlusion and MI. Tousoulis and colleagues found that stable lesions were more likely to have a smooth morphology and that the lesions that progressed to cause infarctions were more likely to be of a more complex morphology. The authors concluded that stenosis morphology was more predictive of future events than stenosis severity. It is worth noting that, although complex lesions do seem to increase the risk of future MIs, many such lesions remain stable for years.
Ambrose et al. found that nonQ-wave MI was more likely to occur in coronary arteries having lesions that were greater than 70% stenosed. Tousoulis et al. (4) found similar results, but other investigators have not always confirmed this finding. There is clearly a tendency for severely stenosed coronary arteries to stimulate collateral circulation. These vessels may contribute to the occurrence of a nonQ-wave MI when the culprit artery becomes totally occluded, as opposed to an extensive Q-wave infarction when such collaterals are not present (5).
An important challenge today is how to identify the minor or silent plaques that carry a high risk of thrombosis. As revealed by pathological examination, these plaques usually contain a large lipid core and a thin fibrous cap with an abundance of inflammatory cells. Angiography, despite its demonstrated usefulness and ability to identify the underlying degree of stenoses (and even their morphology in patients with coronary artery disease), is limited in its ability to identify these vulnerable plaques. Other techniques may be useful in the future for identifying these lesions. Intravascular ultrasound and angioscopy can identify the presence of thrombosis and, in some cases, the lipid-rich vulnerable plaques themselves. However, their ability to predict subsequent coronary events needs further evaluation. In addition, these techniques are invasive and may not be practical on a routine basis in patients with stable coronary artery disease. Magnetic resonance imaging is offering some promising new developments in the evaluation of ischemic heart disease. As this technique develops, it may be able to characterize the components of a plaque in terms of lipid, fibrous and thrombotic material. Another noninvasive technique that may be used for detecting high-risk, vulnerable plaques is electron beam (ultrafast) computed tomography. This test is best at diagnosing the degree of calcium content in coronary arteries; however, although calcium content may be correlated with coronary artery disease, its ability to predict plaque vulnerability has yet to be demonstrated by clinical studies.
The treatment of stable coronary disease must be aimed at stabilizing these vulnerable plaques, which are at risk of becoming a site for acute thrombosis. Plaque stabilization and improvement of endothelial function are best accomplished by lipid-lowering medication in the appropriate patient population. Antithrombotic agents are useful in decreasing thrombus formation and, thus, preventing acute occlusion and subsequent potentially life-threatening clinical events. More research in this area is needed in order to discover how best to identify and treat those patients with stable coronary artery disease who are at increased risk for MI.
| Introduction |
|---|
|
|
|---|
The working group responsible for selecting these articles and asking reviewers to write editorials solicited suggestions from the ACCs clinical committees and individual members.
The group achieved consensus fairly easily, including whom the group should ask to prepare the accompanying editorials. We initially drew up a list of 14 general areas to cover in this series, but later found that there are several major areas of modern cardiology, prominently molecular cardiology, in which the truly landmark articles have, alas, not yet been published in JACC. Therefore, the working group decided not to categorize by subject, but instead, to concentrate on the most important articles.
The working group, a task force of the Subcommittee for the Commemoration of the ACC 50th Anniversary, owes a great deal to Ms. May A. Roustom and the efficient and tireless staff at Heart House for facilitating this project. We also wish to thank all who suggested articles and, most important, the authors who prepared reviews for their willingness to contribute their time and wisdom.
Influential Articles in JACC Working Group
Sharon A. Hunt, M.D., F.A.C.C.
Rick A. Nishimura, M.D., F.A.C.C.
H.J.C. Swan, M.D., Ph.D., M.A.C.C.
Michael J. Wolk, M.D., F.A.C.C.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |